title: Leukemia inhibitory factor as a mediator of lipopolysaccharide effects on appetite and selected hormones and metabolites.
abstract: Leukemia inhibitory factor (LIF) has been suggested to function as a potent inhibitor of feed intake in rodents. In sheep, intravenous injection of lipopolysaccharide (LPS) resulted in an increase in gene expression for LIF in the arcuate nucleus ( < 0.01). In the same experiment, agouti related protein (AgRP) expression was elevated ( < 0.05) but there were no effects on proopiomelanocortin expression. Another group of sheep were provided intracerebroventricular (ICV) injections of LIF at 250, 500, 1,000, and 2,500 ng per sheep. Cumulative feed intake was inhibited by the 1,000- and 2,500-ng doses at 8 and 10 h after ICV injection ( < 0.03). All doses of LIF elevated temperature above 40°C, indicating a fever. When AgRP was intracerebroventricularly injected before LIF, there was no effect of LIF to reduce feed intake, suggesting the LIF inhibition of feed intake is consistent with the concept that the effect is mediated by the melanocortin-4 receptor. In an experiment to determine whether endocrine and metabolic effects of LIF were similar to reported effects of LPS, sheep were intracerebroventricularly injected with 2,500 ng LIF, and blood samples were collected at 10-min intervals for 6 h for assay of LH, samples from the first 3 h were assayed for GH, and samples at 30-min intervals were assayed for glucose and free fatty acids. The effect of treatment and treatment × time interaction was significant, indicating elevated plasma free fatty acids ( < 0.03 and < 0.001, respectively) and glucose ( < 0.01 and < 0.0001, respectively). There was also a treatment × time interaction on circulating concentrations of LH such that LIF caused LH to decrease ( < 0.0001). Additionally, there was a tendency for LIF treatment to increase circulating concentrations of GH (P = 0.0874). The effects of LIF on feed intake and other parameters was similar to the effects of LPS and leads to a hypothesis that LIF expression in response to LPS may be a component of the mechanism for feed intake inhibition and perhaps for changes in selected hormone and metabolites in disease models.
authors.forename: J A
authors.initials: JA
authors.lastname: Daniel
authors.forename: B K
authors.initials: BK
authors.lastname: Whitlock
authors.forename: D L
authors.initials: DL
authors.lastname: Marks
authors.forename: J A
authors.initials: JA
authors.lastname: Gard
authors.forename: J L
authors.initials: JL
authors.lastname: Sartin
mesh_terms: D054369:Agouti-Related Protein / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001066:Appetite / Q000187:drug effects; D004435:Eating / Q000187:drug effects* / Q000502:physiology; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005786:Gene Expression Regulation; D053605:Leukemia Inhibitory Factor / Q000008:administration & dosage / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000633:toxicity*; D007986:Luteinizing Hormone; D044105:Receptor, Melanocortin, Type 4 / Q000235:genetics / Q000378:metabolism; D012756:Sheep / Q000502:physiology*; D013997:Time Factors
chemical_list: D054369:Agouti-Related Protein; D005230:Fatty Acids, Nonesterified; D053605:Leukemia Inhibitory Factor; D008070:Lipopolysaccharides; D044105:Receptor, Melanocortin, Type 4; D007986:Luteinizing Hormone